nutritional priorities to support glp-1 therapy for obesity GLP‐1 obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society PDF) Nutritional Priorities to Support

Cons: App-based communication only, limited individualization

Monitoring: Patients with recurrent infections (three or more episodes per year, per CDC definition) require further evaluation to identify underlying causes, which may include uncontrolled diabetes, immunosuppression, or non-albicans Candida species that may require culture and susceptibility testing

GLP1s reduce thirst and saliva production, and suppress appetite

A recent study by Legg et al. reported that the monthly prevalence of obesity in U.S

Primary Care-Based Programs Many primary care providers now include GLP-1 treatment within broader healthcare services